Collagen Hybridizing Peptides allow for quantification of NASH Disease Activity
info@3helix.com
Collagen Hybridizing Peptides allow for quantification of NASH Disease Activity
Collagen Remodeling Activity Significantly Higher in Faster Progressors of NAFLD/NASH.
When trying to identify the disease activity of NASH, there is limited information researchers have access to when determining how a patient’s fibrosis will progress. Researchers currently use stains like Picrosirius Red or Masson’s Trichrome which show the total collagen content of a slide.
By using Collagen Hybridizing Peptides (CHPs), researchers have more information to make crucial decisions. CHPs have been used to remove the heterogeneity of a patient group, clearly showing that fast progressors have a higher amount of remodeling collagen compared to the total collagen present and that slow progressors’ collagen is made up of stable scar tissue. In addition to visualizing and monitoring the progression of fibrosis, CHPs can also quantify the pauses in fibrosis in response to treatment as a secondary endpoint.
Collagen Hybridizing Peptides can Identify fibrosis in many other hepatic conditions, including but not limited to:
We highly recommend using our In Vivo CHPs to investigate these conditions
Our In Vivo CHPs are conjugated with sCy 7.5 for near-IR detection. Contact us for customized conjugates.
Contact UsThanks for subscribing!
This email has been registered!